Boston, MA, United States of America

Gavin Ha

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Dana-Farber-Cancer Institute Inc., Harvard College, The Broad Institute, Inc.. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Genome Characterization by Gavin Ha

Introduction

Gavin Ha is an accomplished inventor based in Boston, MA. He has made significant contributions to the field of genomics, particularly in the characterization of genomes. His innovative work has led to the development of methods that enhance our understanding of tumor DNA.

Latest Patents

Gavin Ha holds a patent for "Methods for Genome Characterization." This invention provides methods of using low coverage sequencing to assess the relative fraction of tumor versus normal DNA in a sample. It also allows for the assessment of copy number alterations present in the sample. This patent represents a crucial advancement in cancer research and diagnostics.

Career Highlights

Throughout his career, Gavin has worked with prestigious organizations such as the Broad Institute, Inc. and Dana-Farber Cancer Institute. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer genomics.

Collaborations

Gavin has collaborated with notable colleagues, including Samuel Freeman and Viktor A. Adalsteinsson. These partnerships have further enriched his research and contributed to the advancement of genomic studies.

Conclusion

Gavin Ha's innovative methods for genome characterization exemplify the impact of his work in the field of genomics. His contributions are paving the way for improved cancer diagnostics and treatment strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…